Enliven Therapeutics, Inc.
ELVN
$36.32
$0.210.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.24% | 47.59% | 63.64% | 57.02% | -9.66% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 125.40% | 164.56% | 0.18% | -9.92% | -28.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.36% | 49.27% | 62.52% | 55.79% | -12.72% |
|
|
|||||
| Total Current Assets | 57.36% | 49.27% | 62.52% | 55.79% | -12.72% |
| Net Property, Plant & Equipment | -70.62% | -8.95% | 38.73% | 29.71% | 14.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -80.48% | -87.83% | -6.22% | -10.90% | 54.64% |
| Total Assets | 53.63% | 46.17% | 60.72% | 54.07% | -11.73% |
|
|
|||||
| Total Accounts Payable | 4.99% | 60.88% | 40.24% | 117.08% | -42.72% |
| Total Accrued Expenses | -20.68% | -4.94% | -18.84% | 9.32% | 2.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.26% | -- | 355.29% | 122.49% | 44.84% |
| Total Finance Division Other Current Liabilities | -26.71% | 72.06% | -60.19% | -99.34% | -98.60% |
| Total Other Current Liabilities | -26.71% | 72.06% | -60.19% | -99.34% | -98.60% |
| Total Current Liabilities | -17.79% | 4.10% | -13.96% | -31.19% | -44.18% |
|
|
|||||
| Total Current Liabilities | -17.79% | 4.10% | -13.96% | -31.19% | -44.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -19.53% | 4.10% | -13.36% | -30.28% | -43.05% |
|
|
|||||
| Common Stock & APIC | 47.15% | 45.76% | 56.04% | 56.51% | 13.21% |
| Retained Earnings | -36.31% | -42.59% | -44.13% | -50.84% | -53.52% |
| Treasury Stock & Other | -2,287.50% | 507.27% | -8.68% | -27.34% | 69.81% |
| Total Common Equity | 57.26% | 48.33% | 65.09% | 60.19% | -9.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.26% | 48.33% | 65.09% | 60.19% | -9.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.26% | 48.33% | 65.09% | 60.19% | -9.26% |
|
|
|||||